Role of Clinical Exome Sequencing in Diagnostic...
Transcript of Role of Clinical Exome Sequencing in Diagnostic...
![Page 1: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/1.jpg)
Role of Clinical Exome Sequencing in Diagnostic Odyssey
Pinar Bayrak-Toydemir, MD, PhDProfessor, Department of Pathology, University of Utah
Medical Director, Molecular Genetics and Genomics, ARUP Laboratories
![Page 2: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/2.jpg)
- Description of exome sequencing
- Results of our clinical exome casesDetection rate based on clinical findings and trio vs proband
- Exome Sequencing interesting case discussions
- Guidelines and Recommendations
Outline
![Page 3: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/3.jpg)
Next Generation Sequencing in Molecular Diagnosis
A powerful tool for gene discovery
200 genes are discovered every year
Now a powerful diagnostic tool !
Changed the way we think aboutscientific approaches in basic, applied and clinical research and
diagnostics
![Page 4: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/4.jpg)
Next Generation Sequencing Cost Dropping
http://www.genome.gov/sequencingcosts/
![Page 5: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/5.jpg)
Of approximately ∼19,000 protein‐coding genes predicted to
exist in the human genome, variants that cause Mendelian
phenotypes have been identified in ∼3,303 genes
TThttps://www.omim.org/statistics/geneMap
![Page 6: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/6.jpg)
New 2016 OMIM Disease‐Associated Genes
TT
72
241411
998
76
6 5 4 4 4 4 3 2 2
NeurologicalSyndromesImmunologicalEyeSkeletalMuscleCardiacMitochondrialMetabolicBloodReproductiveCiliopathiesGastrointestinalKidneyHearingEctodermalHeterotaxy
N=179
![Page 7: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/7.jpg)
Exome Sequencing
Sequencing of coding regions of all known genes
‐ Balanced to cover and obtain full coverage across the medically relevant genes in the human exome
‐ 100% coverage of all exons in 3,000 of the 4,600 disease associated genes making it the most comprehensive exome sequencing test available
![Page 8: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/8.jpg)
Exome sequencing
– Allows for identification of pathologic variants in newly identified disease genes
– Useful for conditions with locus heterogeneity (long molecular differentials)
– Unexpected/expanded phenotypic variation
TT
![Page 9: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/9.jpg)
Exome Diagnostic Yield in Known Disease Genes in Children
TT
Clin Genet 2016; 89: 275–228.
![Page 10: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/10.jpg)
Clinical Sensitivity
Clinical sensitivity may change based on the test ordered and also based on clinical presentation.
• Neurodevelopmental disorders‐ yield around 73%• Autism‐ yield around 28%• Epilepsy‐30%
(Soden et al, 2014)(Lee et al., 2014)
(Juusola et al., 2015)
![Page 11: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/11.jpg)
Clinical Sensitivity
De novo variants are reported when both parent’s samples are available for exome sequencing; 35‐50% of diagnoses were achieved by identification of de novo variants.
Compound heterozygous/homozygous variants (30%) are reported for autosomal recessive conditions related to the patient’s symptoms.
X‐linked mutations are 10%
![Page 12: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/12.jpg)
Diagnostic Yield
Positive, 34%
VUS, 6%
Negative, 60%
![Page 13: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/13.jpg)
Inheritance Pattern Positive Cases
Courtesy of Tatiana Tvrdik
38, 39%
5, 5%
4, 4%
5, 5%10, 10%
11, 11%
25, 26%
Dominant de novo
Dominant ‐ proband only
Dominant inherited
X‐linked de novo
X‐linked ‐ mother carrier
Homozygous
Compound heterozygous
![Page 14: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/14.jpg)
Proband Only vs Trios Diagnostic Yield
Positive,25%
VUS, 6%Negative69%
Proband Only
Positive, 36%
Negative, 14, 64%
Incomplete Trio
Positive, 37%
VUS, 7%
Negative, 56%
Trio
Positive, 44%
VUS, 7%
Negative, 49%
Trio Plus
Courtesy of Tatiana Tvrdik
![Page 15: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/15.jpg)
TT
Power of Trio in Exome Testing
• De novo variants
• Potential to identify parent-of-origin of de novo variants
• Compound heterozygotes and complex variants
• Homozygous vs apparent homozygous variants
• Reduced number of variants to be considered as causative
![Page 16: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/16.jpg)
Diagnostic Yield by Age
Newborn Infant Child Adolescent Adult
Positive and Negative
46%54%
39%
61%
37%
63%
18%
82% 80%20%
Courtesy of Tatiana Tvrdik
![Page 17: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/17.jpg)
Causative Disorders
34, 37%
33, 36%
7, 8%
5, 5%4, 4%
4, 4% 2, 2%1, 1% 1, 1%
1, 1%
1, 1% SyndromesNeurologicalMuscularVascularMetabolicMitochondrialSkeletalCilliopathyHearingGastrointestinalHematological
Courtesy of Tatiana Tvrdik
![Page 18: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/18.jpg)
Cases with No Molecular Diagnosis
97, 55%53, 30%
5, 3%8, 4% 3, 2%
3, 2%
1, 0%1, 0%
1, 1%1, 1%
1, 1%
1, 1%
Multiple anomaliesNeurologicalMuscularImmunodeficiencySkeletalGastrointestinalVascularCilliary dyskinesiaMitochondrialFailure to thriveSarcomasXanthomas
Courtesy of Tatiana Tvrdik
![Page 19: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/19.jpg)
TT
Limitations of Our Exome Sequencing
The following will not be identified:
• Some coding regions, amenable to capture
• Any genetic changes residing outside of the targeted regions
• Repeat expansions
• Low level of mosaicism
• Structural DNA variation: translocations, inversions, insertions/deletions (indels) and copy number variations
• Mitochondrial genome variants
![Page 20: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/20.jpg)
Exome Sequencing Laboratory Workflow
Genomic DNA
Shearing
Library PrepHybridization to exome
capture probes
Barcoding
Cluster Generation Sequencing
Bioinformatics Analysis
Variant Classifications
Courtesy of Tatiana Tvrdik
![Page 21: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/21.jpg)
Case Discussion
![Page 22: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/22.jpg)
Distal Arthrogryposis: finger elbow and knee contractures, ulnar deviation, and fixed thumb adduction, difficulty in opening jaw
MicroArray : 409kb gain at 4q32.2
Dysmorphic featuresNarrow palpebral fissures, blepharophimosis, prominent nasolabial folds, small mouth, dimpling on chin, retrognathia and low‐set ears
Dave Stevenson, MD, Kathryn Swoboda, MD
![Page 23: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/23.jpg)
DISORDER CLINICAL MANIFESTATION GENETIC BASIS TEST RESULT
Stuve Wiedmannsyndrome (SWS)
ArgthrogryposisLong bone bowing
Autonomic dysregulationEarly death
LIFRAutosomalRecessive
Negative_1 Variant VUS
Freeman Sheldon Syndrome
Face, hands, and feet"whistling face“; chin dimple shaped
like an "H" or "V“; malignant hyperthermia
MYH3AutosomalDominant
Negative_Nodisease causing
mt noted
![Page 24: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/24.jpg)
![Page 25: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/25.jpg)
Proband
Father
Mother
c.46G>A; p.Asp16Asn 2688‐71G>A
![Page 26: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/26.jpg)
WT c.2668-71G>A
c.2668
GT AG
-71
AGAC
A
LIFR c.2668-71G>A
![Page 27: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/27.jpg)
• Gene: LIFR (NM_002310)
• Variant: – c.46G>A; p.Asp16Asn (one copy) - Variant of Uncertain
Significance– c.2336-71G>A (one copy)- Variant of Uncertain Significance
• Inheritance pattern: Autosomal recessive
![Page 28: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/28.jpg)
![Page 29: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/29.jpg)
Proband
Father
Mother
c.1768C>T; p.Leu590Phe
![Page 30: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/30.jpg)
Na+, K+, and Ca(2+)
• Mainly expressed in CNS
• Synapse development and synaptic density (Lu et al., 2007)
• KO mice: die of respiratory rhythm
NALCN(Cochet‐Bissuel 2014)
Ion channel
Voltage‐independent
Non‐selective
Non‐inactivating
Courtesy of Eric Bend and Erik Jorgensen
![Page 31: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/31.jpg)
Autosomal recessive inheritance
Koroglu et al. J Med Genet 2013
Al‐Sayed et al. J Hum Genet 2013
Putative dominant inheritance ?
Hypertonia ‐ distal contractures ?
Infant mortality ?
Mild to severe hypotonia
Viable
Courtesy of Eric Bend and Erik Jorgensen
![Page 32: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/32.jpg)
Extracellular
Intracellular
Na
Na NaNa
Human variant from clinical exome (L590F)
Courtesy of Eric Bend and Erik Jorgensen
![Page 33: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/33.jpg)
PredictionsDominant inheritance HypertoniaIncreased neurotransmission
Wild Type NCA-1 GoFHypertonic
NCA-1 LOFHypotonic
Semi-dominantRecessive
Courtesy of Eric Bend and Erik Jorgens
![Page 34: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/34.jpg)
Human SNPGain‐of‐FunctionWild Type
Courtesy of Eric Bend and Erik Jorgensen
![Page 35: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/35.jpg)
35
![Page 36: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/36.jpg)
Public database filtering
![Page 37: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/37.jpg)
a 7-year-old boy of hispanic/native american/caucasian ancestry
Other Testing Results:MRI showed a small optic chiasm, focal encephalomalacia or dilated perivascular spaces.
The patient had a normal genomic microarray.
Clinical Findings:Pre and postnatal overgrowth, Moderate ID,Not typical Sotos face, Advanced bone age, History of laryngomalacia,Hypotonia,No history of seizure,Mild optic nerve hypoplasia John Carey, MD
![Page 38: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/38.jpg)
Variants in targeted genes: 56,890
Variants: 1,582
Variants : 1,738
Hemizygous variant shared with mom on X
chr: 25
Compound heterozygous or homozygous variants :
20
De novo: 3 1 FBN1
1 DNMT3A 1 TRAM2
Subtract common variant of frequency >1% and internal frequency 3%
Exclude intergenic, 5’and 3’ UTRs, and noncoding RNA
AR, X‐linked
Variants in HGMD/OMIM located on exons or
junction +/‐10:461
AD
Exclude parent homozygous
![Page 39: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/39.jpg)
This FBN1 variant (p.Arg1632Cys) alters a moderately conserved aminoacid and creates an extra cysteine residue between cysteine residues 4and 5 (Cys1631 and Cys1633) in the EGF-like calcium-binding domain27.
FBN1 protein contains 47 epidermal growth factor (EGF)-like domainswhich are characterized by six conserved cysteine residues. These sixcysteine residues form three disulfide bonds that are critical for thenormal protein structure of FBN1.
Cysteine substitutions that disrupt one of the three disulfide bonds arefrequent causes of Marfan syndrome.
![Page 40: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/40.jpg)
Computational analyses predict that this FBN1 variant (p.Arg1632Cys)will affect protein function (SIFT: deleterious, MutationTaster: diseasecausing, PolyPhen-2: probably damaging).
In addition, it is only reported in one individual in the Exome AggregationConsortium database (1 out of 121378 alleles).
Although this particular FBN1 variant (p.Arg1632Cys) has not beenreported in the literature, a different amino acid alteration at the samecodon (p.Arg1632His) has been reported in a patient that met Ghentcriteria for Marfan syndrome with ocular findings and no skeletal orcardiovascular findings .
![Page 41: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/41.jpg)
![Page 42: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/42.jpg)
![Page 43: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/43.jpg)
![Page 44: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/44.jpg)
Tatton-Brown et al. Nat Genet 2014
![Page 45: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/45.jpg)
![Page 46: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/46.jpg)
• Median age 60• Age range 55-80• Allelic ratio: Ranges 10-48%• 11 individuals–Somatic data from cancer tissue• 55 individuals- Germline data
![Page 47: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/47.jpg)
It affects the highly conservedmethyltransferase domain and reducesmethyltransferase activity by approximately80% compared to the wild type protein, whichresults in focal hypomethylation at specificCpG sites throughout genome
DNMT3A: c. 2645G>A, p.Arg882His
![Page 48: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/48.jpg)
Somatic DNMT3A variants are commonly foundin patients with hematologic malignancies and inpatients with age-related clonal hematopoiesiswithout overt disease but with increased risk forsubsequent development of a hematologicmalignancy.
The p.Arg882His variant is the most commonsomatic variant of DNMT3A observed in patientswith age-related clonal hematopoiesis orhematologic malignancies
![Page 49: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/49.jpg)
GUIDELINES/REGULATIONSCLIA/CAP/ACMG
![Page 50: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/50.jpg)
Guide validation of samples, analysis and reporting
Genetics in Medicine, 2013
![Page 51: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/51.jpg)
“Direct laboratories to return with each genomic sequencing order results from 57 genes in which mutations greatly increase risk of 24 serious, but treatable diseases, even if clinicians do not suspect patients have them.”
![Page 52: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/52.jpg)
“Direct laboratories to return with each genomic sequencing order results from 57 genes in which mutations greatly increase risk of 24 serious, but treatable diseases, even if clinicians do not suspect patients have them.”
59 genes
![Page 53: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/53.jpg)
Variants found by exome/genome sequencing , which are unrelated to the disease of interest
- majority of them are benign- a small number of them (between 1-5) might be well-described, disease-associated mutations
What are incidental (or secondary) findings?
![Page 54: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/54.jpg)
Incidental Findings
The ACMG Working Group recommended that the laboratory actively search for the specified types of mutations in the specified genes listed in these recommendations.
Mandatory reporting known mutations for the disorders:- Hereditary cancers, - Marfan syndrome, - Long QT syndrome, - Brugada syndrome, - Certain cardiomyopathies
![Page 55: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/55.jpg)
“Recommendations for seeking and reporting incidental findings not be limited by the age of the person being sequenced.
The ethical concerns about providing children with genetic risk information about adult-onset diseases were outweighed by the potential benefit to the future health of the child and the child’s parent of discovering an incidental finding where intervention might be possible.”
Returning incidental findings in children
![Page 56: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/56.jpg)
- Proband and family members need to consent for exome sequencing and incidental finding
- the ACMG Working Group revised document offers the patient a preference as to whether or not to receive the minimum list of incidental findings described in these recommendations.
Patient Consent and Opt‐in/out option
![Page 57: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/57.jpg)
57
Around 90% of cases would like to receive secondary findings
ARUP secondary finding frequency is 1-2%
![Page 58: Role of Clinical Exome Sequencing in Diagnostic Odysseyarup.utah.edu/media/bayrakToydemir-clinicalExome...Pinar Bayrak-Toydemir, MD, PhD Professor, Department of Pathology, University](https://reader036.fdocuments.net/reader036/viewer/2022062607/60255ffa1a6f1e500a306e08/html5/thumbnails/58.jpg)
Conclusion
58
• Clinical exome sequencing is effective to diagnosis heterogeneous disorders, non-specific or atypical presentation, especially for neurological and neuromuscular disorders
• Sensitivity depends on- Medical Exome enrichment - Including intronic regions and promoter regions to our bed file - Collaboration with clinicians - Follow up functional studies
• Quality control measures, data analysis and reporting of incidental findings will continue to evolve and improve